Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)

Celgene · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
carcinomahepatocellular-carcinomanivolumabsafety
carcinoma, hepatocellular, cc-122, nivolumab, hepatocellular carcinoma, phase 1/2, safety, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 840935
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.